Viz Vascular is a comprehensive suite of AI-powered workflow solutions designed to enhance the efficiency and effectiveness of patient care for vascular teams. The platform optimizes clinical workflows by providing hyperfast vascular imaging across any device, reliable AI-powered screening for multiple vascular diseases, and real-time collaboration tools for efficient communication among care teams. It helps establish urgency and coordinate care by delivering relevant patient information promptly.

The suite includes specialized modules such as Viz™ Pulmonary Embolism, which offers AI-powered clot detection and automated RV/LV ratio calculation. This module securely detects and triages central and segmental embolisms, expediting treatment decisions and facilitating communication through a built-in chat. Another key module, Viz Aortic Disease, provides AI-powered detection of suspected abdominal aortic aneurysm (AAA) and aortic dissection. Viz.ai emphasizes unparalleled accuracy and performance, with published post-market validation demonstrating high sensitivity and specificity for PE, Aortic, and AAA detection. By improving diagnostic acumen and expediting critical decision-making, Viz Vascular aims to save lives and improve patient outcomes.

Features & Benefits

• AI-Powered Vascular Screening: Provides reliable, hyperfast AI-powered screening for multiple vascular diseases, including pulmonary embolism and aortic conditions, across any device.
• Pulmonary Embolism (PE) Module: Offers AI-driven clot detection, automated RV/LV ratio calculation, and secure triage of central & segmental embolisms to expedite treatment decisions.
• Aortic Disease Module: Enables AI-powered detection of suspected abdominal aortic aneurysm (AAA) and aortic dissection with high accuracy.
• Real-time Care Coordination: Facilitates efficient communication and collaboration among care teams with built-in chat and relevant patient information sharing.
• Validated Accuracy & Performance: Demonstrates high sensitivity and specificity (e.g., PE 91%/92%, Aortic 96%/98%, AAA 96%/95%) with real-world post-market validation.